[Prevention of leukopenia caused by antimitotic treatment with diethyldioxystilbendipropionate].
D050256:Antimitotic Agents; D035843:Biomedical Research; D004054:Diethylstilbestrol / Q000627:therapeutic use*; D007958:Leukocyte Count; D007960:Leukocyte Disorders; D007970:Leukopenia; D009151:Mustard Gas / Q000009:adverse effects*; D014965:X-Rays / Q000009:adverse effects
D050256:Antimitotic Agents; D004054:Diethylstilbestrol; D009151:Mustard Gas
DIETHYLSTILBESTROL/therapeutic use; LEUKOCYTE COUNT; MUSTARD GAS/injurious effects; ROENTGEN RAYS/injurious effects
Die Verhinderung der durch antimitotische Behandlung hervorgerufenen Leukopenie vermittels Diäthyldioxystilbendipropionat.